Literature DB >> 27471965

Mitochondria and Cancer.

Sejal Vyas1, Elma Zaganjor1, Marcia C Haigis2.   

Abstract

Mitochondria are bioenergetic, biosynthetic, and signaling organelles that are integral in stress sensing to allow for cellular adaptation to the environment. Therefore, it is not surprising that mitochondria are important mediators of tumorigenesis, as this process requires flexibility to adapt to cellular and environmental alterations in addition to cancer treatments. Multiple aspects of mitochondrial biology beyond bioenergetics support transformation, including mitochondrial biogenesis and turnover, fission and fusion dynamics, cell death susceptibility, oxidative stress regulation, metabolism, and signaling. Thus, understanding mechanisms of mitochondrial function during tumorigenesis will be critical for the next generation of cancer therapeutics.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27471965      PMCID: PMC5036969          DOI: 10.1016/j.cell.2016.07.002

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  99 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Effects of hypoxia and HIFs on cancer metabolism.

Authors:  Vera Mucaj; Jessica E S Shay; M Celeste Simon
Journal:  Int J Hematol       Date:  2012-04-27       Impact factor: 2.490

3.  BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response.

Authors:  Kristopher A Sarosiek; Xiaoke Chi; John A Bachman; Joshua J Sims; Joan Montero; Luv Patel; Annabelle Flanagan; David W Andrews; Peter Sorger; Anthony Letai
Journal:  Mol Cell       Date:  2013-09-26       Impact factor: 17.970

Review 4.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

5.  Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation.

Authors:  Joyce V Lee; Alessandro Carrer; Supriya Shah; Nathaniel W Snyder; Shuanzeng Wei; Sriram Venneti; Andrew J Worth; Zuo-Fei Yuan; Hee-Woong Lim; Shichong Liu; Ellen Jackson; Nicole M Aiello; Naomi B Haas; Timothy R Rebbeck; Alexander Judkins; Kyoung-Jae Won; Lewis A Chodosh; Benjamin A Garcia; Ben Z Stanger; Michael D Feldman; Ian A Blair; Kathryn E Wellen
Journal:  Cell Metab       Date:  2014-07-03       Impact factor: 27.287

6.  MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.

Authors:  Patricia Sancho; Emma Burgos-Ramos; Alejandra Tavera; Tony Bou Kheir; Petra Jagust; Matthieu Schoenhals; David Barneda; Katherine Sellers; Ramon Campos-Olivas; Osvaldo Graña; Catarina R Viera; Mariia Yuneva; Bruno Sainz; Christopher Heeschen
Journal:  Cell Metab       Date:  2015-09-10       Impact factor: 27.287

Review 7.  The interplay between MYC and HIF in cancer.

Authors:  Chi V Dang; Jung-whan Kim; Ping Gao; Jason Yustein
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

Review 8.  Mitochondrial reactive oxygen species and cancer.

Authors:  Lucas B Sullivan; Navdeep S Chandel
Journal:  Cancer Metab       Date:  2014-11-28

9.  Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.

Authors:  Rebecca Lamb; Hannah Harrison; James Hulit; Duncan L Smith; Michael P Lisanti; Federica Sotgia
Journal:  Oncotarget       Date:  2014-11-30

10.  Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.

Authors:  Saverio Tardito; Anaïs Oudin; Shafiq U Ahmed; Fred Fack; Olivier Keunen; Liang Zheng; Hrvoje Miletic; Per Øystein Sakariassen; Adam Weinstock; Allon Wagner; Susan L Lindsay; Andreas K Hock; Susan C Barnett; Eytan Ruppin; Svein Harald Mørkve; Morten Lund-Johansen; Anthony J Chalmers; Rolf Bjerkvig; Simone P Niclou; Eyal Gottlieb
Journal:  Nat Cell Biol       Date:  2015-11-23       Impact factor: 28.824

View more
  397 in total

Review 1.  Mitochondrial dynamics as regulators of cancer biology.

Authors:  Andrew Paul Trotta; Jerry Edward Chipuk
Journal:  Cell Mol Life Sci       Date:  2017-01-12       Impact factor: 9.261

2.  Propafenone suppresses esophageal cancer proliferation through inducing mitochondrial dysfunction.

Authors:  Wei-Bin Zheng; Yang-Jia Li; Yang Wang; Jie Yang; Can-Can Zheng; Xiao-Hui Huang; Bin Li; Qing-Yu He
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

Review 3.  Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.

Authors:  Shaohua Ma; Chorlada Paiboonrungruan; Tiansheng Yan; Kevin P Williams; M Ben Major; Xiaoxin Luke Chen
Journal:  Ann N Y Acad Sci       Date:  2018-05-11       Impact factor: 5.691

4.  Spatially Restricting Bioorthogonal Nucleoside Biosynthesis Enables Selective Metabolic Labeling of the Mitochondrial Transcriptome.

Authors:  Kim Nguyen; Mahima B Aggarwal; Chao Feng; Gabriela Balderrama; Michael Fazio; Ali Mortazavi; Robert C Spitale
Journal:  ACS Chem Biol       Date:  2018-05-17       Impact factor: 5.100

5.  Aurora kinase A localises to mitochondria to control organelle dynamics and energy production.

Authors:  Giulia Bertolin; Anne-Laure Bulteau; Marie-Clotilde Alves-Guerra; Agnes Burel; Marie-Thérèse Lavault; Olivia Gavard; Stephanie Le Bras; Jean-Philippe Gagné; Guy G Poirier; Roland Le Borgne; Claude Prigent; Marc Tramier
Journal:  Elife       Date:  2018-08-02       Impact factor: 8.140

Review 6.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

7.  Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.

Authors:  Alejandro Schcolnik-Cabrera; Alma Chávez-Blanco; Guadalupe Domínguez-Gómez; Alfonso Dueñas-González
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

8.  MicroRNA-211 Loss Promotes Metabolic Vulnerability and BRAF Inhibitor Sensitivity in Melanoma.

Authors:  Anupama Sahoo; Sanjaya K Sahoo; Piyush Joshi; Bongyong Lee; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2018-08-01       Impact factor: 8.551

Review 9.  MOTS-c: A Mitochondrial-Encoded Regulator of the Nucleus.

Authors:  Bérénice A Benayoun; Changhan Lee
Journal:  Bioessays       Date:  2019-08-05       Impact factor: 4.345

Review 10.  Targeted Metabolic Reprogramming to Improve the Efficacy of Oncolytic Virus Therapy.

Authors:  Barry E Kennedy; Maryanne Sadek; Shashi A Gujar
Journal:  Mol Ther       Date:  2020-03-20       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.